GIC-Backed Syngene Inks to acquire Stelis Biopharma’s Unit
New Delhi: A drug research company, Syngene International Ltd, backed by Singapore sovereign wealth fund GIC, is set to acquire Stelis Biopharma’s manufacturing unit in Bengaluru for Rs 702 crore...
